143 related articles for article (PubMed ID: 9878625)
1. Functional analysis of vaccinia virus B5R protein: role of the cytoplasmic tail.
Lorenzo MM; Herrera E; Blasco R; Isaacs SN
Virology; 1998 Dec; 252(2):450-7. PubMed ID: 9878625
[TBL] [Abstract][Full Text] [Related]
2. Functional analysis of vaccinia virus B5R protein: essential role in virus envelopment is independent of a large portion of the extracellular domain.
Herrera E; Lorenzo MM; Blasco R; Isaacs SN
J Virol; 1998 Jan; 72(1):294-302. PubMed ID: 9420227
[TBL] [Abstract][Full Text] [Related]
3. The extracellular domain of vaccinia virus protein B5R affects plaque phenotype, extracellular enveloped virus release, and intracellular actin tail formation.
Mathew E; Sanderson CM; Hollinshead M; Smith GL
J Virol; 1998 Mar; 72(3):2429-38. PubMed ID: 9499104
[TBL] [Abstract][Full Text] [Related]
4. Replacing the SCR domains of vaccinia virus protein B5R with EGFP causes a reduction in plaque size and actin tail formation but enveloped virions are still transported to the cell surface.
Rodger G; Smith GL
J Gen Virol; 2002 Feb; 83(Pt 2):323-332. PubMed ID: 11807225
[TBL] [Abstract][Full Text] [Related]
5. The cytoplasmic and transmembrane domains of the vaccinia virus B5R protein target a chimeric human immunodeficiency virus type 1 glycoprotein to the outer envelope of nascent vaccinia virions.
Katz E; Wolffe EJ; Moss B
J Virol; 1997 Apr; 71(4):3178-87. PubMed ID: 9060681
[TBL] [Abstract][Full Text] [Related]
6. A mutational analysis of the vaccinia virus B5R protein.
Mathew EC; Sanderson CM; Hollinshead R; Smith GL
J Gen Virol; 2001 May; 82(Pt 5):1199-1213. PubMed ID: 11297695
[TBL] [Abstract][Full Text] [Related]
7. Deletion of the vaccinia virus B5R gene encoding a 42-kilodalton membrane glycoprotein inhibits extracellular virus envelope formation and dissemination.
Wolffe EJ; Isaacs SN; Moss B
J Virol; 1993 Aug; 67(8):4732-41. PubMed ID: 8331727
[TBL] [Abstract][Full Text] [Related]
8. Intracellular localization of vaccinia virus extracellular enveloped virus envelope proteins individually expressed using a Semliki Forest virus replicon.
Lorenzo MM; Galindo I; Griffiths G; Blasco R
J Virol; 2000 Nov; 74(22):10535-50. PubMed ID: 11044098
[TBL] [Abstract][Full Text] [Related]
9. The vaccinia virus 42-kDa envelope protein is required for the envelopment and egress of extracellular virus and for virus virulence.
Engelstad M; Smith GL
Virology; 1993 Jun; 194(2):627-37. PubMed ID: 8503178
[TBL] [Abstract][Full Text] [Related]
10. Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteins.
Ward BM; Weisberg AS; Moss B
J Virol; 2003 Apr; 77(7):4113-26. PubMed ID: 12634370
[TBL] [Abstract][Full Text] [Related]
11. Antibodies against the extracellular enveloped virus B5R protein are mainly responsible for the EEV neutralizing capacity of vaccinia immune globulin.
Bell E; Shamim M; Whitbeck JC; Sfyroera G; Lambris JD; Isaacs SN
Virology; 2004 Aug; 325(2):425-31. PubMed ID: 15246280
[TBL] [Abstract][Full Text] [Related]
12. Epitope-mapping studies define two major neutralization sites on the vaccinia virus extracellular enveloped virus glycoprotein B5R.
Aldaz-Carroll L; Whitbeck JC; Ponce de Leon M; Lou H; Hirao L; Isaacs SN; Moss B; Eisenberg RJ; Cohen GH
J Virol; 2005 May; 79(10):6260-71. PubMed ID: 15858010
[TBL] [Abstract][Full Text] [Related]
13. Golgi network targeting and plasma membrane internalization signals in vaccinia virus B5R envelope protein.
Ward BM; Moss B
J Virol; 2000 Apr; 74(8):3771-80. PubMed ID: 10729152
[TBL] [Abstract][Full Text] [Related]
14. The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus.
Roper RL; Wolffe EJ; Weisberg A; Moss B
J Virol; 1998 May; 72(5):4192-204. PubMed ID: 9557708
[TBL] [Abstract][Full Text] [Related]
15. Extracellular vaccinia virus formation and cell-to-cell virus transmission are prevented by deletion of the gene encoding the 37,000-Dalton outer envelope protein.
Blasco R; Moss B
J Virol; 1991 Nov; 65(11):5910-20. PubMed ID: 1920620
[TBL] [Abstract][Full Text] [Related]
16. Visualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.
Ward BM; Moss B
J Virol; 2001 May; 75(10):4802-13. PubMed ID: 11312352
[TBL] [Abstract][Full Text] [Related]
17. Neutralizing and protective antibodies directed against vaccinia virus envelope antigens.
Galmiche MC; Goenaga J; Wittek R; Rindisbacher L
Virology; 1999 Feb; 254(1):71-80. PubMed ID: 9927575
[TBL] [Abstract][Full Text] [Related]
18. Vaccinia virus glycoprotein A34R is required for infectivity of extracellular enveloped virus.
McIntosh AA; Smith GL
J Virol; 1996 Jan; 70(1):272-81. PubMed ID: 8523536
[TBL] [Abstract][Full Text] [Related]
19. A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope.
Engelstad M; Howard ST; Smith GL
Virology; 1992 Jun; 188(2):801-10. PubMed ID: 1585649
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope.
Isaacs SN; Wolffe EJ; Payne LG; Moss B
J Virol; 1992 Dec; 66(12):7217-24. PubMed ID: 1433514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
